ARCHIVES

“Treatment INDs” Seen As Major Threat To Clinical Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 34 | August 21, 1987

Download PDF Visit The Full Archive

Related Articles

Roche Reports New Avastin Results As FDA Mulls Breast Cancer Indication.

February 15, 2008

Gallo, Four Others Share Lasker Award

November 19, 1982

“Action Steps” Listed For Prostate Research In National Blueprint

January 16, 1998

Survey Finds 70 Percent of Oncologists Prescribe Avastin Off-Label For Ovarian Cancer

August 30, 2013

UICC Seeks Nominations for Mucio Athayde Prize.

January 7, 2000

Ultmann Appeals For Better Funding, Cancer Act Renewal

June 28, 1985